Investing for Cystic Fibrosis.
Flatley Venture Capital is an investment firm with a special interest in bringing treatments for Cystic Fibrosis and other pulmonary diseases to market.
Flatley Venture Capital is dedicated to improving the lifespan and quality of life of patients suffering from respiratory diseases.
Flatley Venture Capital invests in early-stage companies with innovative therapies for Cystic Fibrosis and other pulmonary disorders.
Flatley Venture Capital is able to offer portfolio companies office or laboratory space in Boston or New Hampshire.